Paradigm Biopharmaceuticals Ltd (PAR) - Total Liabilities

Latest as of December 2025: AU$17.16 Million AUD ≈ $12.14 Million USD

Based on the latest financial reports, Paradigm Biopharmaceuticals Ltd (PAR) has total liabilities worth AU$17.16 Million AUD (≈ $12.14 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Paradigm Biopharmaceuticals Ltd (PAR) long-term investment share to see how much of total assets are deployed in long-term investments.

Paradigm Biopharmaceuticals Ltd - Total Liabilities Trend (2014–2025)

This chart illustrates how Paradigm Biopharmaceuticals Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see how large is Paradigm Biopharmaceuticals Ltd's balance sheet.

Paradigm Biopharmaceuticals Ltd Competitors by Total Liabilities

The table below lists competitors of Paradigm Biopharmaceuticals Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Se Gyung Hi Tech Co.Ltd KQ:148150	Korea	₩111.76 Billion
NFC Corporation KQ:265740	Korea	₩24.88 Billion
Aifeex Nexus Acquisition Corporation NASDAQ:AIFE	USA	$1.17 Million
Ampire Co Ltd TWO:8049	Taiwan	NT$336.28 Million
The Platform Group AG XETRA:TPG	Germany	€180.25 Million
Bon Fame Co Ltd TWO:8433	Taiwan	NT$2.26 Billion
E-Data Teknoloji Pazarlama AS IS:EDATA	Turkey	TL301.17 Million
KHD Humboldt Wedag International AG XETRA:KWG	Germany	€137.23 Million

Liability Composition Analysis (2014–2025)

This chart breaks down Paradigm Biopharmaceuticals Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Paradigm Biopharmaceuticals Ltd balance sheet independence to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.31	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	2.86	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.74	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Paradigm Biopharmaceuticals Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Paradigm Biopharmaceuticals Ltd (2014–2025)

The table below shows the annual total liabilities of Paradigm Biopharmaceuticals Ltd from 2014 to 2025.

Year	Total Liabilities	Change
2025-06-30	AU$3.39 Million ≈ $2.40 Million	-5.49%
2024-06-30	AU$3.58 Million ≈ $2.54 Million	-73.23%
2023-06-30	AU$13.39 Million ≈ $9.48 Million	+59.88%
2022-06-30	AU$8.38 Million ≈ $5.93 Million	+28.49%
2021-06-30	AU$6.52 Million ≈ $4.61 Million	+55.88%
2020-06-30	AU$4.18 Million ≈ $2.96 Million	+54.62%
2019-06-30	AU$2.70 Million ≈ $1.91 Million	+103.80%
2018-06-30	AU$1.33 Million ≈ $939.01K	+38.92%
2017-06-30	AU$955.29K ≈ $675.93K	-14.45%
2016-06-30	AU$1.12 Million ≈ $790.13K	+93.42%
2015-06-30	AU$577.33K ≈ $408.49K	+56.60%
2014-06-30	AU$368.67K ≈ $260.85K	--

About Paradigm Biopharmaceuticals Ltd

AU:PAR Australia Biotechnology

Market Cap

$91.09 Million

AU$128.74 Million AUD

Market Cap Rank

#19628 Global

#642 in Australia

Share Price

AU$0.25

Change (1 day)

+0.00%

52-Week Range

AU$0.14 - AU$0.45

All Time High

AU$4.35